The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $319,990 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Minnesota. The 36-month grant supports a randomized controlled trial to evaluate the use of continuous glucose monitoring (CGM) to personalize medical nutrition therapy for improving glycemic control and self-efficacy in adults with type 2 diabetes mellitus. The project aims to determine if CGM-informed personalized nutrition therapy is superior to medical nutrition therapy alone or unblinded CGM use alone for improving glycemic outcomes. The study will also assess the acceptability, treatment satisfaction, and diabetes self-efficacy of the CGM-informed personalized nutrition approach. Findings from this initiative are expected to generate preliminary data towards a larger multisite trial examining the effectiveness of this novel intervention for type 2 diabetes management.
Generated 1/28/25, 9:13 AM